Tongkat Ali: Independent Evidence on Testosterone, Libido & Safety

Table of contents

• Evidence summary
• What Tongkat Ali is
• All forms and grades
• How it works
• The hype vs the evidence
• Benefits by claim
• What works and what does not
• Risks and all side effects
• All interactions
• Who should avoid Tongkat Ali
• Dosage and how to take
• Animal and in-vitro evidence excluded
• Independent funding and conflict notes
• Frequently asked questions
• Sources and funding notes

Evidence summary

Claim	Evidence	Source	Funding/conflict	Strength
Raises total testosterone (hypogonadal/stressed men)	Meta-analysis, 5 RCTs, SMD 1.352 (95% CI 0.565–2.138), p = 0.001	Leisegang 2022, Medicina	Academic (Univ. Western Cape; Tulane Urology); no manufacturer funding declared	Moderate
Improves erectile function (IIEF-5)	Meta-analysis, 2 RCTs, 139 men; no significant overall difference (WMD 0.91; 95% CI −1.50 to 3.33); high heterogeneity (I²=89.5%)	Kotirum 2015, Complement Ther Med	Academic (Monash/USM/Naresuan); independent but sparse	Weak
Reduces cortisol, raises testosterone under stress	4-week RCT, 63 stressed adults; cortisol −16%, salivary testosterone +37%	Talbott 2013, J Int Soc Sports Nutr	Authors affiliated with SupplementWatch, Biotropics Malaysia (extract maker), and MonaVie — conflicted, downgraded	Contested
General "T-booster" for healthy young men	No dedicated independent RCT in eugonadal young men shows reliable, clinically meaningful gains	Leisegang 2022, Medicina	Independent meta-analysis notes effects less consistent in normal-testosterone men	Insufficient
Liver safety at recommended doses	Case reports of clinically apparent liver injury, mostly in multi-ingredient bodybuilding products	NIH LiverTox; single-agent case report, PMC	Government database / case report; independent	Contested

What Tongkat Ali is

Tongkat Ali is the common name for Eurycoma longifolia, a slender understory shrub native to Malaysia, Indonesia, Thailand, and other parts of Southeast Asia, sometimes called "Malaysian ginseng" even though it is botanically unrelated to true ginseng. Traditional use centers on the root, which has long been prepared as a boiled decoction and consumed for general vitality and male reproductive health. Modern supplements use concentrated root extracts sold as capsules or powders, most commonly standardized to marker compounds called eurypeptides and glyco-saponins (Talbott 2013, J Int Soc Sports Nutr).

Tongkat Ali has become a fixture of the "biohacker" and men's-wellness supplement stack, frequently discussed alongside testosterone optimization content associated with podcasters like Andrew Huberman, and is commonly paired with Fadogia agrestis in commercial "T-boosting" blends. Google search interest in Tongkat Ali has grown sharply, reflecting this online momentum (NowPatient; nsdr.co).

All forms and grades

Form	Standardization / description	Typical source	Notes
Hot-water root extract	Standardized to eurypeptides and glyco-saponins	Market standard for capsules/powders	Most human trials use this extract type (Talbott 2013)
Physta / LJ100-type branded extracts	Proprietary standardized hot-water extracts	Biotropics Malaysia (Physta) and other branded suppliers	Most positive single-brand RCTs use these extracts; company-funded trials should be read cautiously
Concentration ratios (100:1, 200:1)	Root-to-extract concentration ratio	Capsule/powder labeling convention	Higher ratio numbers imply more concentrated extract, but ratios alone do not guarantee a specific eurypeptide content
Capsules	Encapsulated standardized extract, typically 200–400 mg/day total	Most common commercial format	Dosing based on standardized-extract trials, not raw root
Powder	Loose standardized extract powder	Sold for mixing into drinks	Same standardization concerns as capsules
Traditional root decoction	Boiled whole or chopped root, unstandardized	Traditional Southeast Asian preparation	Not represented in the modern clinical-trial evidence base; potency and eurypeptide content are unverified

How it works

The leading proposed mechanism is that Tongkat Ali compounds displace testosterone from sex-hormone-binding globulin (SHBG), a blood protein that binds most circulating testosterone and renders it biologically inactive. By freeing bound testosterone, the extract is hypothesized to raise free testosterone without increasing the rate of testosterone synthesis in the testes (Talbott 2013, J Int Soc Sports Nutr). This distinction matters for the marketing claim: Tongkat Ali is generally not described in the human evidence as a "testosterone synthesis booster" the way anabolic-adjacent compounds are marketed; the proposed action is on hormone binding and availability, not production.

This mechanism is plausible and consistent with the pattern seen in trials — effects concentrate in men with low baseline testosterone or elevated stress hormones, where there may be more "bound" testosterone available to be freed, rather than in men who are already eugonadal. No independent human trial in this evidence set directly measures SHBG-testosterone displacement kinetics in a way that fully confirms this mechanism in living humans; it remains the best available explanatory model rather than a proven pathway.

The hype vs the evidence

The dominant online framing is "natural testosterone booster" — a staple of biohacker stacks and podcast-driven male-wellness content, often stacked with Fadogia agrestis (nsdr.co). The actual human evidence is real but narrower and more context-dependent than the marketing suggests.

The strongest, independent signal is Leisegang et al. 2022 (Medicina), a systematic review and meta-analysis pooling 5 RCTs, which found a statistically significant increase in total testosterone (SMD 1.352; 95% CI 0.565–2.138; p = 0.001). The effect was most robust in hypogonadal men (men with clinically low testosterone); results in men with already-normal testosterone were less consistent. The authors are academic researchers (University of the Western Cape; Tulane University Urology) with no manufacturer funding disclosed, making this the best-supported piece of evidence in the file.

For erectile function, the evidence is much sparser. Kotirum et al. 2015 (Complement Ther Med) pooled only 2 RCTs covering 139 men and found no significant overall difference in IIEF-5 erectile function scores (WMD 0.91; 95% CI −1.50 to 3.33), with high heterogeneity between the two trials (I² = 89.5%). A subgroup of men with lower baseline erectile function did show improvement (IIEF-5 +2.15; 95% CI 1.03–3.27), suggesting any benefit may be limited to men who start out with more impaired function, not a general libido/performance enhancer effect for all users.

The most viral-friendly statistic — cortisol down 16%, testosterone up 37% — comes from a 4-week RCT in 63 moderately stressed adults (Talbott 2013, J Int Soc Sports Nutr). This trial also reported improved tension, anger, and confusion scores. However, its authors were affiliated with SupplementWatch, Biotropics Malaysia (the maker of the extract tested), and MonaVie, a direct-sales supplement company. This is a textbook manufacturer-linked conflict, and the trial is downgraded accordingly — it should not be presented as independent confirmation of the "37% testosterone boost" headline that circulates online.

Put together: the independent evidence supports a real, moderate testosterone-related effect concentrated in men who are hypogonadal or under stress, not a universal "testosterone booster" effect for healthy young men optimizing an already-normal hormone profile.

Benefits by claim

Testosterone in hypogonadal or stressed men

Grade: Moderate. The independent meta-analysis of 5 RCTs found a significant total testosterone increase (SMD 1.352; p = 0.001), concentrated in men with low baseline testosterone (Leisegang 2022, Medicina).

Testosterone/cortisol under psychological stress

Grade: Contested. A single RCT reports a large effect (cortisol −16%, testosterone +37%), but the authors have direct ties to the extract manufacturer (Biotropics Malaysia) and affiliated commercial entities, so this cannot be treated as independent confirmation (Talbott 2013).

Erectile function

Grade: Weak. Pooled data from 2 RCTs (139 men) show no significant overall IIEF-5 improvement, with a possible benefit confined to men with lower baseline erectile function (Kotirum 2015, Complement Ther Med).

General "T-boost" / performance in healthy young men

Grade: Insufficient. The independent meta-analysis specifically notes less consistent effects in men who already have normal testosterone, which is the population most targeted by biohacker marketing (Leisegang 2022, Medicina).

What works and what does not

Claim	Verdict	Basis
Raises total testosterone in hypogonadal/stressed men	Moderate support	Independent 5-RCT meta-analysis, p = 0.001 (Leisegang 2022)
Improves erectile function broadly	Weak support	Only 2 small RCTs pooled; no significant overall effect (Kotirum 2015)
"37% testosterone boost" under stress, as headline claim	Contested / conflicted source	Manufacturer- and distributor-affiliated authors (Talbott 2013)
Universal "natural testosterone booster" for all men	Not well supported	Effects concentrate in low-testosterone/stressed subgroups, not eugonadal men (Leisegang 2022)
Safe at any dose long-term	Contested	Case reports of liver injury; long-term safety not established (NIH LiverTox)

Risks and all side effects

Effect	Frequency/severity	Notes	Source
Nausea, GI discomfort	Common, mild	Reported at conventional doses (200–400 mg/day standardized extract)	Talbott 2013; NIH LiverTox
Insomnia, restlessness, irritability	Reported, uncommon	Consistent with a mild stimulant-like or hormone-modulating effect	NIH LiverTox
Clinically apparent liver injury	Rare but serious	Case reports mostly in bodybuilders using multi-ingredient products; a single-agent case has also been published; long-term safety not established	NIH LiverTox; PMC11032125 case report
Product contamination / undisclosed drug adulteration	Documented quality risk	Particularly in "male-enhancement" blends combining Tongkat Ali with other ingredients	NIH LiverTox

All interactions

Drug/substance class	Mechanism/concern	Direction of effect	Recommended caution
Antihypertensives	Tongkat Ali may lower blood pressure	Potential additive blood-pressure lowering	Use with caution; monitor blood pressure
Antidiabetics (insulin, metformin, sulfonylureas)	May affect blood glucose	Potential additive glucose-lowering effect	Monitor blood glucose
Hormone-sensitive conditions/therapies	Proposed testosterone/SHBG-modulating activity	Theoretical additive hormonal effect	Avoid in prostate cancer and other hormone-sensitive conditions
Pregnancy/lactation	No established safety data	Unknown	Avoid

Data gap: Human pharmacokinetic and drug-interaction studies for Tongkat Ali are limited; the interactions above are mechanism-based inferences rather than confirmed findings from dedicated human interaction trials. No systematic human interaction studies with anticoagulants, antidepressants, sedatives, thyroid medication, or statins were identified in the evidence reviewed here — this is a genuine gap in the human evidence base, not a confirmation of safety with these drug classes.

Who should avoid Tongkat Ali

• Pregnant or breastfeeding people — safety not established.
• People with prostate cancer or other hormone-sensitive conditions, given the proposed testosterone/SHBG-modulating mechanism.
• People with liver disease or a history of liver injury, given case reports of clinically apparent liver injury linked to tongkat ali-containing products.
• People taking antihypertensive medication, without medical supervision, due to a possible additive blood-pressure-lowering effect.
• People taking antidiabetic medication, without monitoring, due to a possible additive blood-glucose-lowering effect.
• Anyone buying unregulated "male-enhancement" blends, due to documented risk of contamination and undisclosed drug adulteration.

Dosage and how to take

Form	Typical studied/labeled dose	Notes
Standardized hot-water extract (capsules/powder)	200–400 mg/day, standardized extract	Range described as generally well tolerated in the human evidence reviewed (NIH LiverTox)
Branded extracts (Physta/LJ100-type)	Follow label dosing; trial doses vary by study	Most clinical evidence is on standardized branded extracts, not raw root
Traditional root decoction	Not standardized	Not represented in the modern controlled-trial evidence; potency unverified

Animal and in-vitro evidence excluded

No animal or in-vitro studies were relied upon for the efficacy or mechanism conclusions in this article. The SHBG-displacement mechanism described above is discussed in the human-trial literature itself (Talbott 2013, J Int Soc Sports Nutr) as a proposed explanation rather than a confirmed pathway, but it is not derived here from a non-human data source. All efficacy grades in this article (Moderate for testosterone in hypogonadal/stressed men; Weak for erectile function) are based exclusively on human randomized controlled trials and meta-analyses of human trials.

Independent funding and conflict notes

Source	Funding/affiliation	Independence assessment
Leisegang 2022, Medicina	University of the Western Cape; Tulane University Urology; no manufacturer funding declared	Independent — strongest evidence source in this review
Kotirum 2015, Complement Ther Med	Monash University; Universiti Sains Malaysia; Naresuan University	Independent, but based on only 2 small trials
Talbott 2013, J Int Soc Sports Nutr	Authors affiliated with SupplementWatch, Biotropics Malaysia (extract manufacturer), and MonaVie	Conflicted — manufacturer-linked; downgraded, not used as independent confirmation
NIH LiverTox	US government (National Institutes of Health)	Independent government safety database
EFSA NDA panel minutes	Novel-food dossier filed by Biotropics Malaysia Berhad	Regulatory record; underlying dossier is industry-submitted, reviewed by EFSA (independent regulator)

Readers should note a recurring pattern: many individually positive Tongkat Ali trials use Biotropics Malaysia's "Physta" extract and are company-funded or company-affiliated. The single most independent, methodologically strongest source in this review — the Leisegang 2022 meta-analysis — is also the most cautious, restricting its clearest positive finding to hypogonadal men rather than endorsing a blanket "testosterone booster" claim.

Frequently asked questions

Does Tongkat Ali actually raise testosterone?

In men with low baseline testosterone or under stress, independent pooled trial data show a statistically significant increase in total testosterone (SMD 1.352, p = 0.001) (Leisegang 2022, Medicina). In men who already have normal testosterone, the effect is far less consistent, so the blanket "natural testosterone booster for everyone" framing seen online overstates the evidence.

Is the "cortisol down 16%, testosterone up 37%" stat trustworthy?

It comes from a real RCT, but the study's authors were affiliated with the extract's manufacturer (Biotropics Malaysia) and related commercial entities, so it should be treated as a conflicted, manufacturer-linked result rather than independent proof (Talbott 2013).

Will Tongkat Ali improve erectile function?

The independent evidence is weak. A meta-analysis of just 2 small RCTs (139 men total) found no significant overall improvement in erectile function scores, with a possible benefit only in men who started with more impaired erectile function (Kotirum 2015, Complement Ther Med).

How does Tongkat Ali supposedly work?

The leading hypothesis is that it displaces testosterone from sex-hormone-binding globulin (SHBG), increasing free (biologically active) testosterone, rather than boosting testosterone synthesis directly (Talbott 2013).

Is Tongkat Ali safe?

At conventional doses it appears generally well tolerated, with nausea, insomnia, and irritability reported. However, NIH LiverTox documents case reports of clinically apparent liver injury, mostly in bodybuilders using multi-ingredient products, and states long-term safety is not established (NIH LiverTox). It should be avoided in pregnancy and lactation, and used cautiously by people with liver disease, hormone-sensitive conditions, or on blood-pressure or diabetes medication.

Is Tongkat Ali FDA-approved or a banned substance?

No. In the US it is sold as an unregulated dietary supplement; it has no FDA-affirmed GRAS status and no FDA-authorized health claim. It is not a banned substance, but quality and contamination risks exist in some blended "male-enhancement" products.

Sources and funding notes

• Leisegang et al. 2022, Medicina — independent academic meta-analysis of 5 RCTs on testosterone; no manufacturer funding declared.
• Kotirum et al. 2015, Complementary Therapies in Medicine — independent academic meta-analysis of 2 RCTs on erectile function.
• Talbott et al. 2013, Journal of the International Society of Sports Nutrition — RCT on stress/cortisol/testosterone; authors affiliated with SupplementWatch, Biotropics Malaysia, and MonaVie — conflicted, downgraded.
• NIH LiverTox, NCBI Bookshelf — independent US government drug/supplement safety database; documents liver-injury case reports.
• Case report, PMC — single-agent acute liver-injury case report.
• EFSA NDA Panel minutes — documents Biotropics Malaysia Berhad's novel-food dossier for Tongkat Ali extract in the EU.
• EFSA safety opinion, PMC — EU Novel Food safety assessment process for Tongkat Ali root extract.
• NowPatient — reporting on search-interest growth for Tongkat Ali.
• nsdr.co — reporting on Tongkat Ali's role in biohacker/podcast supplement stacks alongside Fadogia agrestis.

Last reviewed: July 4, 2026.